138 related articles for article (PubMed ID: 31234234)
1. Cost-benefit analysis of clinical pharmacist intervention in preventing adverse drug events in the general chronic diseases outpatients.
Al-Qudah RA; Al-Badriyeh D; Al-Ali FM; Altawalbeh SM; Basheti IA
J Eval Clin Pract; 2020 Feb; 26(1):115-124. PubMed ID: 31234234
[TBL] [Abstract][Full Text] [Related]
2. Home medication management review in outpatients with chronic diseases in Jordan: a randomized control trial.
Basheti IA; Al-Qudah RA; Obeidat NM; Bulatova NR
Int J Clin Pharm; 2016 Apr; 38(2):404-13. PubMed ID: 26960406
[TBL] [Abstract][Full Text] [Related]
3. Pharmacists in humanitarian crisis settings: Assessing the impact of pharmacist-delivered home medication management review service to Syrian refugees in Jordan.
Al Alawneh M; Nuaimi N; Basheti IA
Res Social Adm Pharm; 2019 Feb; 15(2):164-172. PubMed ID: 29661563
[TBL] [Abstract][Full Text] [Related]
4. Value of a Community-Based Medication Management Review Service in Jordan: A Prospective Randomized Controlled Study.
Basheti IA; Tadros OK; Aburuz S
Pharmacotherapy; 2016 Oct; 36(10):1075-1086. PubMed ID: 27582175
[TBL] [Abstract][Full Text] [Related]
5. Economic Outcomes Associated with Safety Interventions by a Pharmacist-Adjudicated Prior Authorization Consult Service.
Jacob S; Britt RB; Bryan WE; Hashem MG; Hale JC; Brown JN
J Manag Care Spec Pharm; 2019 Mar; 25(3):411-416. PubMed ID: 30816815
[TBL] [Abstract][Full Text] [Related]
6. Economic impact of clinical pharmacist interventions in a general tertiary hospital in Qatar.
Abushanab D; Atchan M; Elajez R; Elshafei M; Abdelbari A; Al Hail M; Abdulrouf PV; El-Kassem W; Ademi Z; Fadul A; Abdalla E; Diab MI; Al-Badriyeh D
PLoS One; 2023; 18(6):e0286419. PubMed ID: 37262042
[TBL] [Abstract][Full Text] [Related]
7. Cost savings and cost avoidance with the inpatient clinical pharmacist interventions in a tertiary cancer care hospital.
Abushanab D; Gulied A; Hamad A; Abu-Tineh M; Abdul Rouf PV; Al Hail M; El-Kassem W; El Hajj MS; Al-Badriyeh D
J Oncol Pharm Pract; 2023 Dec; 29(8):1935-1943. PubMed ID: 36946146
[TBL] [Abstract][Full Text] [Related]
8. Cost benefit analysis of clinical pharmacist interventions in medical intensive care unit in Palestine medical complex: Prospective interventional study.
Houso A; Hamdan M; Falana H
Saudi Pharm J; 2022 Dec; 30(12):1718-1724. PubMed ID: 36601501
[TBL] [Abstract][Full Text] [Related]
9. Treatment related problems for outpatients with chronic diseases in Jordan: the value of home medication reviews.
Basheti IA; Qunaibi EA; Bulatova NR; Samara S; AbuRuz S
Int J Clin Pharm; 2013 Feb; 35(1):92-100. PubMed ID: 23104620
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive assessment of treatment related problems in hospitalized medicine patients in Jordan.
Aburuz SM; Bulatova NR; Yousef AM; Al-Ghazawi MA; Alawwa IA; Al-Saleh A
Int J Clin Pharm; 2011 Jun; 33(3):501-11. PubMed ID: 21442286
[TBL] [Abstract][Full Text] [Related]
11. Potential cost savings by prevention of adverse drug events with a novel medication review program.
Fernández EV; Warriner CL; David T; Gordon E; Twigg G; Carroll NV
J Am Pharm Assoc (2003); 2020; 60(3):462-469.e4. PubMed ID: 31948934
[TBL] [Abstract][Full Text] [Related]
12. [Translated article] Implementation of the standardized process of drug therapy evaluation in inpatients and outpatients.
González A; Gutiérrez W; Fuenzalida T; Lizana F; Gutiérrez M; Severino N
Farm Hosp; 2023; 47(6):T254-T260. PubMed ID: 37735005
[TBL] [Abstract][Full Text] [Related]
13. Costs saved and avoided from pharmacist interventions to address drug-related problems identified from outpatient clinics in Jordan.
Al-Taani GM; Muflih SM; Al-Azzam SI; Alzoubi KH
PLoS One; 2024; 19(6):e0302287. PubMed ID: 38843244
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of a computerized drug-monitoring program to detect and prevent adverse drug events and medication non-adherence in outpatient ambulatory care: study protocol of a randomized controlled trial.
Forster AJ; Erlanger TE; Jennings A; Auger C; Buckeridge D; van Walraven C; Tamblyn R
Trials; 2015 Jan; 16():2. PubMed ID: 25572800
[TBL] [Abstract][Full Text] [Related]
15. Cost-outcome description of clinical pharmacist interventions in a university teaching hospital.
Gallagher J; Byrne S; Woods N; Lynch D; McCarthy S
BMC Health Serv Res; 2014 Apr; 14():177. PubMed ID: 24742158
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the impact of pharmaceutical care service on hospitalized patients with chronic kidney disease in Jordan.
AbuRuz SM; Alrashdan Y; Jarab A; Jaber D; Alawwa IA
Int J Clin Pharm; 2013 Oct; 35(5):780-9. PubMed ID: 23884609
[TBL] [Abstract][Full Text] [Related]
17. Implementation of the standardized process of Pharmacotherapeutic evaluation in inpatients and outpatients.
González A; Gutiérrez W; Fuenzalida T; Lizana F; Gutiérrez M; Severino N
Farm Hosp; 2023; 47(6):254-260. PubMed ID: 37198085
[TBL] [Abstract][Full Text] [Related]
18. Clinical and Economic Impact of Pharmacists' Intervention on Care of Pediatric Hematology and Oncology Patients.
Kim HJ; Lee S; Lee YJ; Kim S; Jo YH; Cho YS; An HY; Hong KT; Choi JY; Kang HJ; Shin HY; Lee JY
J Oncol Pharm Pract; 2023 Mar; 29(2):319-325. PubMed ID: 34931912
[TBL] [Abstract][Full Text] [Related]
19. Financial impact of medication reviews by clinical pharmacists to reduce in-hospital adverse drug events: a return-on-investment analysis.
Jermini M; Fonzo-Christe C; Blondon K; Milaire C; Stirnemann J; Bonnabry P; Guignard B
Int J Clin Pharm; 2024 Apr; 46(2):496-505. PubMed ID: 38315303
[TBL] [Abstract][Full Text] [Related]
20. Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN).
Houle SK; Chuck AW; McAlister FA; Tsuyuki RT
Pharmacotherapy; 2012 Jun; 32(6):527-37. PubMed ID: 22552863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
